Navigation Links
DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
Date:8/9/2013

Chicago, IL (PRWEB) August 09, 2013

The prescription drug resource center DrugRisk.com is announcing updated information for patients taking the blood thinner Pradaxa. A federal court overseeing more than 1,000 lawsuits alleging the drug caused internal bleeding recently denied an attempt by the maker of the drug to dismiss a case*.

DrugRisk provides patients taking popular prescription drugs with the latest warnings, recalls, studies and legal news to improve safety and awareness. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Pradaxa is a blood thinner approved by the FDA in 2010 as a stroke preventative for patients with atrial fibrillation. Experts disagree, however, about its risks for internal bleeding. The FDA has advised Pradaxa is no more dangerous than traditional blood thinner warfarin**.

Others, like the Institute for Safe Medication Practices, have warned that patients may be nearly 5 times as likely to die from bleeding with Pradaxa than that from warfarin***. DrugRisk has also added a recent study from the Netherlands which suggests patients taking newer blood thinners like Pradaxa may be 55% more likely to suffer internal bleeding****.

So far, more than 1,133 patients have filed a Pradaxa lawsuit alleging internal bleeding, with cases now consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, DrugRisk has learned that Judge David Herndon, who is overseeing the cases, recently blocked attempts by drug maker Boehringer Ingelheim to dismiss a case in which a man alleges Pradaxa caused him internal bleeding injury*.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugRisk.com or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisk.com today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Judge David Herndon, 7/18/13; aboutlawsuits.com/wp-content/uploads/2013-07-18-Jackson-Order.pdf
**FDA, 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext
*****Judge David Herndon, 7/18/13; aboutlawsuits.com/wp-content/uploads/2013-07-18-Jackson-Order.pdf

Read the full story at http://www.prweb.com/releases/pradaxa-bleeding/litigation-news/prweb11012356.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
2. DrugRisk Update: Panel To Decide Fate of Januvia Lawsuits Next Week
3. DrugRisk Announces Latest Ruling By Judicial Panel on NuvaRing Lawsuits
4. DrugRisk Announces Drop in Yaz Lawsuits As Bayer Commits $1.5 Billion to Settlements
5. DrugRisks Announces Yaz Center With Latest Updates on Blood Clot Warnings and Settlements
6. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
7. DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits
8. Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes
9. DrugRisk News: Federal Panel Issues Latest Mirena Lawsuit Updates
10. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
11. DrugRisks Update: Yaz Class Action Begins in Canada as Settlements Continue in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... (PRWEB) , ... February 17, 2017 , ... ... , drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn Vallecillos ... cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around that ...
(Date:2/18/2017)... ... 2017 , ... A new directory from the Senior Veterans ... connect elderly veterans of America's armed forces to a range of senior care ... on this year's increase in the Veterans Pension with Aid & Attendance for ...
(Date:2/17/2017)... CA (PRWEB) , ... February 17, 2017 , ... ... focus on foundational and sustainable systems change designed to further positively impact the ... “The Board of Trustees has long considered it our duty to seriously consider ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... , **An FDAnews Webinar**, Feb. 22, 2017 — 1:30 p.m. – 2:30 ... questions manufacturers should be asking before selecting an FDA approval pathway? , ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one of ... the 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare management ... recognized across multiple award categories, highlighting four of the organization’s current programs:, ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 16, 2017 Quest Diagnostics (NYSE: ... services, today announced that it has been named one ... Fortune. The annual survey designated Quest ... "Health Care: Pharmacy and Other Services" industry to attain ... company to attain the designation. This is the second ...
(Date:2/16/2017)... STAMFORD, Conn. , Feb. 16, 2017 The ... to the 2017 Best Place to Work in ... . This is the third year in a row that ... places this year to earn the number-two spot in 2017. ... and maintaining workplace excellence. The winners were determined through a ...
(Date:2/16/2017)... Feb. 16, 2017 Summary Provides understanding ... by the worlds leading healthcare companies. ... Description The Global Allergy Partnering Terms and ... and agreements entered into by the world,s leading healthcare companies. ... by value - Deals listed by company A-Z, industry sector, ...
Breaking Medicine Technology: